PlacementTracker Publishes Q1 2019 PIPE and Private Placement Markets League Tables
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/6/2026
- Wall Street ends lower as solid jobs data fuels hawkish Fed bets
- US nonfarm payrolls blow past expectations in August; unemployment rate steady at 4.1%
- BofA's Hartnett says stay long commodities and gold as 'policy panic' works
- Oil ends week higher on renewed US-Iran strikes, diesel hits record
- TikTok owner ByteDance said to secure $29.6bn loan for AI push
- S&P Dow Jones Indices adds Bloom Energy to S&P 500 index
- Citi highlights best Gen AI stocks to own for 2027
- Dell’s earning report was bullish for Intel CPU demand, analyst says
- Netflix raises prices in Germany and Austria, Citi comments
- Wall Street ends lower as solid jobs data fuels hawkish Fed bets
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Johnson & Johnson (JNJ) PT Raised to $140 at Stifel
April 17, 2019 8:43 AM EDTStifel analyst Rick Wise raised the price target on Johnson & Johnson (NYSE: JNJ) to $140.00 (from $135.00) while maintaining a Hold rating. 1Q19 sales and EPS outperformed expectations and management raised operational sales growth and underlying EPS outlooks. The results were buoyed by better-thanexpected Pharmaceutical and... More
Johnson & Johnson (JNJ) PT Raised to $147 at Raymond James
April 17, 2019 7:42 AM EDTRaymond James analyst Jayson Bedford raised the price target on Johnson & Johnson (NYSE: JNJ) to $147.00 (from $145.00) while maintaining a Outperform rating.
growth was still much better than expected, which gives us more confidence in our estimates... MoreJohnson & Johnson (JNJ) PT Raised to $157 at BMO Capital
April 17, 2019 6:56 AM EDTBMO Capital analyst Joanne Wuensch raised the price target on Johnson & Johnson (NYSE: JNJ) to $157.00 (from $154.00) while maintaining a Outperform rating.
Staying On Course in Its Transition Year
tightening EPS to $8.53-$8.63 from $8.50-$8.65
... More